Abstract
Postinfection complications of coronavirus disease 2019 (COVID-19) are still unknown, and one of the long-term concerns in infected people are brain pathologies. The question is that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection may be an environmental factor in accelerating the sporadic neurodegeneration in the infected population. In this regard, induction of protein aggregation in the brain by SARS-CoV-2 intact structure or a peptide derived from spike protein subunits needs to be considered in futures studies. In this paper, we discuss these possibilities using pieces of evidence from other viruses.
| Original language | English |
|---|---|
| Pages (from-to) | 3704-3706 |
| Number of pages | 3 |
| Journal | ACS Chemical Neuroscience |
| Volume | 11 |
| Issue number | 22 |
| DOIs | |
| State | Published - 18 Nov 2020 |
| Externally published | Yes |
Keywords
- Brain
- COVID-19
- SARS-CoV-2
- functional amyloids
- neurodegeneration
- protein aggregation